AI assistant
CONMED Corp — Director's Dealing 2013
Jun 7, 2013
31971_dirs_2013-06-07_2898d863-8726-40eb-af58-43be9db8c283.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-06-05
Reporting Person: GOLDEN JO ANN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-05 | Common Stock | M | 2500 | $30.04 | Acquired | 12413 | Direct |
| 2013-06-05 | Common Stock | F | 2349 | $31.98 | Disposed | 10064 | Direct |
| 2013-06-05 | Common Stock | M | 2500 | $25.70 | Acquired | 12564 | Direct |
| 2013-06-05 | Common Stock | F | 2010 | $31.98 | Disposed | 10554 | Direct |
| 2013-06-05 | Common Stock | M | 500 | $16.46 | Acquired | 11054 | Direct |
| 2013-06-05 | Common Stock | F | 258 | $31.98 | Disposed | 10796 | Direct |
| 2013-06-05 | Common Stock | M | 1000 | $27.63 | Acquired | 11796 | Direct |
| 2013-06-05 | Common Stock | F | 864 | $31.98 | Disposed | 10932 | Direct |
| 2013-06-05 | Common Stock | M | 1000 | $26.09 | Acquired | 11932 | Direct |
| 2013-06-05 | Common Stock | F | 816 | $31.98 | Disposed | 11116 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-05 | Sars (Stock Appreciation Rights) | $30.04 | M | 2500 | Disposed | 2017-05-18 | Common Stock (2500) | Direct |
| 2013-06-05 | Sars (Stock Appreciation Rights) | $25.70 | M | 2500 | Disposed | 2018-05-16 | Common Stock (2500) | Direct |
| 2013-06-05 | Sars (Stock Appreciation Rights) | $16.46 | M | 500 | Disposed | 2019-06-01 | Common Stock (500) | Direct |
| 2013-06-05 | Sars (Stock Appreciation Rights) | $27.63 | M | 1000 | Disposed | 2021-06-01 | Common Stock (1000) | Direct |
| 2013-06-05 | Sars (Stock Appreciation Rights) | $26.09 | M | 1000 | Disposed | 2022-06-01 | Common Stock (1000) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan,
with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's
termination of service provided the Director has completed one full year of service since the date of the award in which
case the SARs shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of
such termination, whichever period is shorter.
F2: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's termination of service provided the Director has completed one full year of service since the date of the award in which case the SARS shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of such termination, whichever period is shorter.
F3: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.